PRESS RELEASE: The Sarcoma Oncology Center Announces Promising Clinical Data for DeltaRex-G Gene Therapy at ESMO 2026, Madrid, Spain

Data update demonstrates significant clinical benefit and survival improvements in advanced chemo-resistant sarcomas, pancreas, breast, and ovarian cancer